Watch this fast pace discussion of treatment options, where it is revealed that the next study to be expected out of the IHU of Marseille would involve some 600 patients.
The resistance to the virus by lupus patients taking regular HCQ medication is also mentioned.
May 4, 2021 This article is about the “8th Day Therapy” concept developed by Dr Shankara Chetty from South Africa, who has treated… (176)
December 21, 2021 In this interview with internationally renowned Dr. Shankara Chetty from South Africa, we discuss the Omicron variant, which is taking… (162)
September 18, 2021 This interview with Jessica Rose, PhD, covers the question of vaccine safety, as it can be evaluated from actual real… (87)
August 15, 2020 Australian radio host Luke Bona interviewed this August 12 Professor Thomas Borody, from the Centre for Digestive Diseases in Sydney,… (80)
August 19, 2020 The Centre for Digestive Diseases issued today a press release titled “Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian… (73)
June 26, 2021 COVID-19 is typically an acute infection caused by SARS-CoV-2 virus that lasts 2-3 weeks. However, in some instances the disease… (59)
July 18, 2021 Our podcast episodes are conveniently available on Spotify, Apple Podcasts, Google Podcasts. Or you can listen to them directly here!… (52)
August 25, 2021 We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with… (36)
March 24, 2021 One of the most active analysts during this pandemic regarding the treatment of COVID-19 has been independent researcher Adam Gaertner.… (31)
April 9, 2020 The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort… (27)
